Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem

Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
The extended-release combination of naltrexone and bupropion (NB-ER) may be used as safe and effective treatment for weight reduction among individuals with overweight/obesity and mild to moderate symptoms of depression, suggests a study.
Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
08 May 2026
Brolucizumab a viable alternative in proliferative diabetic retinopathy
In the treatment of patients with proliferative diabetic retinopathy, brolucizumab outperforms panretinal laser photocoagulation in terms of preserving visual acuity, according to the international phase III CONDOR trial.
Brolucizumab a viable alternative in proliferative diabetic retinopathy
02 May 2026
Semaglutide may avert adult-onset epilepsy in patients with diabetes
Treatment with semaglutide appears effective in reducing the risk of adult-onset epilepsy or seizures relative to sodium–glucose cotransporter-2 inhibitors (SGLT2i) and other glucose-lowering drugs (GLDs) in patients with type 2 diabetes mellitus (T2DM), according to a study presented at AAN 2026.






